Loading publications…
The last 5 uploaded publications
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Arndt Vogel, Andrés Cervantes, Ian Chau, Bruno Daniele, Josep M. Llovet, Tim Meyer, Jean‐Charles Nault, Ulf P. Neumann, Jens Ricke, Bruno Sangro, Peter Schirmacher, Chris Verslype, Francis Zech, Dirk Arnold, Erika Martinelli (2018). Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 29, pp. iv238-iv255, DOI: 10.1093/annonc/mdy308.
Article145 days agoUpdated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines
Arndt Vogel, Erika Martinelli, Arndt Vogel, Andrés Cervantes, Ian Chau, Bruno Daniele, Josep M. Llovet, Tim Meyer, Jean‐Charles Nault, Ulf P. Neumann, Jens Ricke, Bruno Sangro, Peter Schirmacher, Chris Verslype, Francis Zech, Dirk Arnold, Erika Martinelli (2021). Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines. Annals of Oncology, 32(6), pp. 801-805, DOI: 10.1016/j.annonc.2021.02.014.
Article145 days agoCorrection to: “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”
Arndt Vogel, Andrés Cervantes, Ian Chau, Bruno Daniele, Josep M. Llovet, Tim Meyer, Jean‐Charles Nault, U. Neumann, Jens Ricke, Bruno Sangro, Peter Schirmacher, Chris Verslype, Francis Zech, Dirk Arnold, Erika Martinelli (2019). Correction to: “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”. Annals of Oncology, 30(5), pp. 871-873, DOI: 10.1093/annonc/mdy510.
Article145 days agoThe management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
Michel Ducreux, Ghassan K. Abou‐Alfa, Tanios Bekaii‐Saab, Jordan Berlin, Andrés Cervantes, Thierry de Baère, Charis Eng, Peter R. Galle, Sharlene Gill, Thomas Gruenberger, Karin Haustermans, Ángela Lamarca, Pierre Laurent‐Puig, Josep M. Llovet, F. Lordick, Teresa Macarulla, Deborah Mukherji, Kei Muro, Radka Obermannová, Juan Manuel O’Connor, Eileen M. O’Reilly, Pia Österlund, P. A. Philip, G. Prager, Érika Ruiz-García, Bruno Sangro, Thomas Seufferlein, Josep Tabernero, Chris Verslype, Harpreet Wasan, Eric Van Cutsem (2023). The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022. ESMO Open, 8(3), pp. 101567-101567, DOI: 10.1016/j.esmoop.2023.101567.
Article145 days agoCorrigendum to “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”
Peter Vogel, Andrés Cervantes, Ian Chau, Bruno Daniele, Josep M. Llovet, T Meyer, Jean‐Charles Nault, Ulf P. Neumann, Jens Ricke, Bruno Sangro, Peter Schirmacher, Chris Verslype, Francis Zech, Dirk Arnold, E. Martinelli (2022). Corrigendum to “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”. , 33 (6), DOI: https://doi.org/10.1016/j.annonc.2022.03.009.
Corrigendum44 days ago